{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:52:08Z","timestamp":1783529528041,"version":"3.55.0"},"reference-count":38,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,1,22]]},"DOI":"10.1080\/14656566.2021.2006183","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T15:09:15Z","timestamp":1641913755000},"page":"169-173","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Evaluating upadacitinib for the treatment of psoriatic arthritis"],"prefix":"10.1080","volume":"23","author":[{"given":"Akpabio","family":"Akpabio","sequence":"first","affiliation":[{"name":"Rheumatology Department, Royal Hallamshire Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewale","family":"Adebajo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04446-z"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.01.003"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14667"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1002\/art.40726"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"cit0006","unstructured":"Recommendations | spondyloarthritis in over 16s: diagnosis and management | guidance | NICE [Internet]. NICE; cited 2021 Jul 18. Available from: https:\/\/www.nice.org.Uk\/guidance\/ng65\/chapter\/Recommendations"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1964-1"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key339"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20977777"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1657404"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa815"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.124"},{"issue":"1","key":"cit0013","first-page":"314","volume":"80","author":"Mease PJ","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"cit0014","unstructured":"PubChem. Upadacitinib [Internet]. [cited 2021 Jul 30]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/58557659"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-018-0031-x"},{"key":"cit0016","unstructured":"AbbVie. European commission approves AbbVie\u2019s RINVOQTM (Upadacitinib) for the treatment of psoriatic arthritis and ankylosing spondylitis [Internet]. [cited 2021 Jul 17]. Available from: https:\/\/www.prnewswire.com\/news-releases\/european-commission-approves-abbvies-rinvoq-upadacitinib-for-the-treatment-of-psoriatic-arthritis-and-ankylosing-spondylitis-301214178.html"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0605-6"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00739-3"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1550"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00855-0"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01211-z"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.462"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13329"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0419-y"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1513"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key276"},{"key":"cit0027","first-page":"280","volume":"76","author":"Nurmohamed M","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1002\/art.39801"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1002\/art.39808"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1002\/art.41032"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1002\/art.41384"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022516"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218870"},{"key":"cit0034","author":"Muensterman E","year":"2021","journal-title":"Clin Transl Sci"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.439"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.397"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008250"},{"key":"cit0038","unstructured":"2 Information about upadacitinib | upadacitinib for treating severe rheumatoid arthritis | guidance | NICE [Internet]. NICE; [cited 2021 Jul 17]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta665\/chapter\/2-Information-about-upadacitinib"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.2006183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T04:31:32Z","timestamp":1642739492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.2006183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,22]]}},"alternative-id":["10.1080\/14656566.2021.2006183"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.2006183","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}